Gibson Dunn & Crutcher advised Hahn & Company on the deal. South Korea’s largest private equity firm, Hahn & Company, announced closing Hahn & Company IV,...
Hahn & Company’s $3.4 Billion Closing of Fourth Korea Buyout Fund
PAR Technology Corporation’s Acquisition of Stuzo Holdings
Gibson, Dunn & Crutcher advised PAR Technology Corporation on the transaction. PAR Technology Corporation (NYSE: PAR) (the “Company” or “PAR”) announced it has completed the acquisition of Stuzo...
PAR Technology Corporation’s Acquisition of TASK Group
Gibson, Dunn & Crutcher advised PAR Technology Corporation on the transaction, and Winston & Strawn represented Longshore Capital Partners, as the Seller Representative. PAR Technology Corporation...
XOMA’s Acquisition of Kinnate Biopharma
XOMA was represented by Gibson, Dunn & Crutcher LLP. XOMA Corporation (NASDAQ: XOMA) announced it has entered an agreement to acquire Kinnate Biopharma Inc. (NASDAQ: KNTE) for a...
GE HealthCare Technologies Inc.’s Secondary Offering
Gibson, Dunn & Crutcher LLP advised GE Healthcare Technologies Inc. on the pricing of the secondary underwritten public offering. GE HealthCare Technologies Inc. (Nasdaq: GEHC) priced the...
Compass Diversified’s Partnership with The Honey Pot Company
Perella Weinberg Partners served as exclusive financial advisor and Winston & Strawn LLP acted as legal counsel to The Honey Pot Co., while Gibson, Dunn &...
Appian Capital Advisory LLP’s Closing of $2.06 Billion Fund III
Gibson, Dunn & Crutcher LLP advised Appian Capital Advisory LLP on the matter. Appian Capital Advisory LLP, the investment advisor to long-term value focused private capital funds that...
Tower Arch Capital’s Recapitalization of TD&I Cable Maintenance
Gibson, Dunn & Crutcher and BDO USA advised Tower Arch Capital, and Hennepin Partners and Fabyanske, Westra, Hart & Thomson, PA. advised TD&I Cable Maintenance, LLC...
General Electric’s $1.95 Billion Debt-for-Equity Exchange
Gibson Dunn advised GE HealthCare Technologies, Paul, Weiss advised General Electric, and Simpson Thacher advised the representatives of the underwriters. Simpson Thacher also represented Morgan Stanley...
Wafra’s Investment in Greenbelt Capital Partners
Gibson, Dunn & Crutcher LLP served as legal advisor to Wafra. Kirkland & Ellis LLP served as legal advisor to Greenbelt. Capital Constellation (“Constellation”), an investment...
Calumet Specialty Products Partners’ $325 Million Private Placement
Gibson, Dunn & Crutcher LLP is advising Calumet Specialty Products Partners, L.P. on its offering. Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) (the “Partnership” or “Calumet”) and...
Magenta Therapeutics’ Merger with Dianthus Therapeutics
Gibson, Dunn & Crutcher LLP acted for Dianthus Therapeutics, Inc. on its merger with Magenta Therapeutics, Inc., assisted by Goodwin Procter. Magenta Therapeutics, Inc. (Nasdaq: MGTA) and Dianthus Therapeutics,...